Supplying the international market of two-photon excitation microscopy, femtonics kft. boasts nobel-laureate customers.

Founded in 2005, the wholly Hungarianowned enterprise employs 36 people continuously seeking an additional 50 people in their ongoing development projects. The company’s kick off enjoyed the best of two worlds: domestic knowledge capital and excellent sense of business were brought together by physicist-neuroscientists Balázs Rózsa and Gergely Katona. As a result, Femtonics’s market share on the global market of two-photon excitation microscopy has already reached fi ve percent by now.

The company plunged into the market in 2013, launching state-of-the-art technology solutions including their currently worldleading 3D laser scanning microscope. The equipment – developed according to the specific requirements of neuroscience – has revolutionised this field of research by offering a million times faster measurement speed than that of the competitors as well as the possibility of scanning at cell level. At present, they are about to introduce the demo version of a brand new microscope product line by the end of the year, in order to make the technology widely accessible on the global market, at a considerably lower price than that of the standard model. With currently as many as 34 international patents in their pocket, the philosophy of Femtonics has not changed for a decade: research and product development is carried out “in-house”, that means in one place and within a single team – their spending on innovation and R&D has demanded a share of nearly thirty percent from revenues over the past four years.

They are dedicated to keeping knowledge at home, therefore they are organising a technology hub referred to as iTechCity, in which Hungarian companies are granted the opportunity to collaborate with Hungarian scientists on international patents under favourable employment conditions. By successfully deploying international and European Union grants, they have an ample chance to work on further high-key technology improvements as well as research on exploring the brain and finding cures for neurological diseases.